October 2, 2008: VentriPoint Diagnostics LTD. engages CHF investor relations
and reports approval of shares issued to directors and consultants as payment for services

September 10, 2008: VentriPoint Diagnostics Announces Private Placement of Equity Financing

August 29,2008: VentriPoint Diagnostics Files Management Discussion and
Analysis, Unaudited Financial Results for 2Q 2008

July 1, 2008: VentriPoint Appoints Mary-Pierre Waiss Vice President of Clinical Development

June 3, 2008: VentriPoint Diagnostics Files Management Discussion and Analysis, Unaudited Financial
Results for Q1, 2008

May 8, 2008: Medical Device Daily: VentriPoint develops better method of RV measurement
Written after the completion of the tetralogy of fallot database, the article discusses the medical need for
accurate measurements of the right ventricle and how the VentriPoint Diagnostic System fills this need. 
The article also provides a brief overview of how VentriPoint’s Knowledge Based Reconstruction technique
creates accurate 3-dimensional models and volume measurements of the right ventricle.
View the full article on-line here. (Subscription required)

April 30, 2008: VentriPoint Diagnostics Files Management Discussion and Analysis, Audited Financial Results

April 29, 2008: Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular
Volume and Function in Tetralogy of Fallot Patients

April 24, 2008: VentriPoint, University of Washington Sign Research
and Technology Development agreement

April 8, 2008: Three Dimensional Visualization of Right Ventricle Provides Important Information
for Treatment of Patients with Tetralogy of Fallot, According to a Study in The
American Journal of Cardiology

March 2008: VentriPoint Diagnostics Announces the Committee Membership of its
Newly Elected Directors

February 2008: VentriPoint Diagnostics Retains Russo Partners as Communications Counsel

September 2007: VentriPoint goes public via a reverse merger with Luca Capital (stock symbol: VPT)

April 2007: Luca to Acquire Ventripoint as Qualifying Transaction

February 2006: Scientific Advisory Board created, initial membership: Dr. Mark Lewin, M.D. Seattle Children’s Hospital; Dr. Tom Jones, M.D. Seattle Children’s Hospital

February 2006: Signed collaboration agreement with Zurich University to collect MRI data.

January 2006: Treuman Katz joins the VentriPoint Board of Directors.

January 2006: Key development team hired.

 

VentriPoint Diagnostics Ltd. is a public Canadian company with its common shares traded on the TSX Venture Exchange under the symbol "VPT", its only operations being those of VentriPoint, Inc.

Complete and continuous disclosure documents, including audited financial statements can be found at: http://www.sedar.com/